Search NUTX
Nutex Health Inc.
Nasdaq · CIK 1479681
Last close216.5
Daily change+4.19 (1.97%)
10 Years gain-96.39%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NUTX · STANDARD
SIC 7389 · Services-Business Services, NEC · Fiscal year end 1231
Fundamental
86.4Momentum
77.4Acceleration
48.7Confidence
79.0Annual Revenue16
Quarterly Revenue63
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality22.1 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 5.8446 percentage points.
Operating leverageOperating margin improved by 5.4744 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Heavy share dilution · HIGHDiluted share count increased 8.8327%.
ROIC declining · MEDIUMROIC declined by 8.8724 percentage points.
Key Metrics
Revenue Growth TTM50.42%OK
Revenue CAGR 3Y58.62%OK
Gross Margin54.61%OK
Operating Margin39.09%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC164.2%OK
Incremental Operating Margin 3Y106.84%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y8.83%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $875.26M | $444.28M | $275.63M | $248.13M | $245.60M | 50.76% | 31.49% | 28.06% | 128.92% | 6.76M |
| 2025 FY Dec 31, 2024 | $479.95M | $196.26M | $130.70M | $23.15M | $20.85M | 40.89% | 27.23% | 4.34% | 109.95% | 5.49M |
| 2025 FY Dec 31, 2023 | $247.65M | $34.77M | -$31.77M | $1.26M | -$8.24M | 14.04% | -12.83% | -3.33% | -28.89% | 4.41M |
| 2024 FY Dec 31, 2022 | $219.29M | $15.42M | -$406.60M | $50.61M | $35.97M | 7.03% | -185.41% | 16.4% | -242.68% | 4.23M |
| 2023 FY Dec 31, 2021 | $331.53M | $179.28M | $170.26M | $173.43M | n/a | 54.08% | 51.36% | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $939.03M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-054268, 0001628280-25-053166 |
| Revenue Growth TTM | 50.42% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-054268, 0001628280-25-053166 |
| Revenue CAGR 3Y | 58.62% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-015168 |
| Revenue CAGR 5Y | 26.14% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-015168 |
| Gross Profit CAGR 3Y | 206.55% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-015168 |
| Operating Income Growth | 74.92% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-054268, 0001628280-25-053166 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 54.61% | Gross Profit / Revenue | OK | 0001628280-26-054268, 0001628280-25-053166 |
| Operating Margin | 39.09% | Operating Income / Revenue | OK | 0001628280-26-054268, 0001628280-25-053166 |
| ROIC | 164.2% | NOPAT / Average Invested Capital | OK | 0001628280-26-054268, 0001628280-25-053166 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-054268 |
| Current Ratio | 5x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 5.18x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-054268 |
| Revenue per Diluted Share | $133.74 | Revenue / Diluted Shares | OK | 0001628280-26-054268, 0001628280-25-053166 |